DeepMed™ - A global indication competitive intelligence

A one-stop platform for pipeline development monitoring and clinical value evaluation from the perspective of indications

DeepMed™ database is a one-stop indication competition landscape research platform, focusing on subdivided indications, integrating the latest clinical trials, clinical results, regulatory approvals, clinical guidelines, and epidemiology at home and abroad. Based on the drug R&D scenario and AI+HI data processing methodology, DeepMed™ builds a complete evidence chain to illustrate the clinical value, and gain in-depth insights into the competitive landscape of global innovative drugs under subdivided indications, comprehensively evaluate the clinical value of the pipeline, and help accelerate the launch of products.

DeepMed™ constructs a one-stop knowledge platform centered on subdivided indications.

DeepMed™ is developed around a core concept called "subdivided indications" , which includes the concept of clinical stage, biomarker, pathology, baseline characteristics, etc.. With the combination of line (such as neoadjuvant, adjuvant, first-line, second-line, etc.), DeepMed™ provides a clear view of the pivotal trials, clinical outcomes, regulatory approvals, guideline-recommended regimens, and epidemiology etc., under each subdivided indications.

关键临床试验

可查询细分适应症下国内外开展的关键临床试验开展情况，包含对应临床结果、监管获批事件、指南证据。

临床结果

丰富的数据源及结构化数据，助力清晰查询细分适应症下的临床结果。临床结果收录更全面，终点结果更清晰。

监管获批

可查看细分适应症下中、美、欧创新药监管获批情况，含特殊通道、审评文档及新闻资料，包含对应的关键临床试验证据及对应指南推荐情况。

指南推荐

可调研中外权威指南的治疗方案、循证依据和治疗路径，对比不同国家或地区指南推荐方案的差异，了解指南变更历史。

流病数据

了解细分适应症下的国内外患者发病率、生存率、死亡率等情况，辅助判断市场潜力和临床需求。

What's Special